The use of weight-loss drugs like Ozempic and Wegovy is increasing in the U.S., leading to a shift in the market. Companies like WeightWatchers are facing competition as more Americans turn to GLP-1 receptor agonists for weight control, with Oprah Winfrey revealing her use of these drugs.
WeightWatchers has faced more competition recently from GLP-1 prescriptions drugs like Ozempic and Wegovy sometimes used for weight loss. https://t.co/iYWFQqYEIt https://t.co/iYWFQqYEIt
WeightWatchers has faced more competition recently from GLP-1 prescriptions drugs like Ozempic and Wegovy sometimes used for weight loss. https://t.co/MwZLItIEFy
WeightWatchers and other diet companies have struggled amid a shift toward so-called GLP-1 drugs like Ozempic, which rely on hormones to control appetite. Oprah Winfrey disclosed last year that she relies on these drugs to maintain her weight. https://t.co/1SQ9fTThAK
A plethora of new weight-loss drugs are now available in the U.S., but they aren’t necessarily the same. Here’s a guide to the latest GLP-1 receptor agonists https://t.co/GASwkCq9MX
The big health decisions Americans will need to make after starting new weight loss drugs https://t.co/nGA6kDIThP
Ozempic and other weight-loss drug use is booming. But are Americans on board? https://t.co/KRwNVIauuV